Biocomposite Based on Polylactic Acid and Rice Straw for Food Packaging Products.

Plastic containers, commonly produced from non-biodegradable petroleum-based plastics such as polyethylene (PE), polypropylene (PP), and polyethylene terephthalate (PET), raise significant environmental concerns due to their persistence. The disposal of agricultural waste, specifically rice straw (RS), through burning, further compounds these environmental issues. In response, this study explores the integration of polylactic acid (PLA), a biodegradable material, with RS using a twin-screw extruder and injection process, resulting in the creation of a biodegradable packaging material. The inclusion of RS led to a decrease in the melt flow rate, thermal stability, and tensile strength, while concurrently enhancing the hydrophilic properties of the composite polymers. Additionally, the incorporation of maleic anhydride (MA) contributed to a reduction in the water absorption rate. The optimized formulation underwent migration testing and met the standards for food packaging products. Furthermore, no MA migration was detected from the composite. This approach not only provides a practical solution for the disposal of RS, but also serves as an environmentally-friendly alternative to conventional synthetic plastic waste.

Utilization of Waste Natural Fibers Mixed with Polylactic Acid (PLA) Bicomponent Fiber: Incorporating Kapok and Cattail Fibers for Nonwoven Medical Textile Applications.

Disposable surgical gowns are usually made from petroleum-based synthetic fibers that do not naturally decompose, impacting the environment. A promising approach to diminish the environmental impact of disposable gowns involves utilizing natural fibers and/or bio-based synthetic fibers. In this study, composite webs from polylactic acid (PLA) bicomponent fiber and natural fibers, cattail and kapok fibers, were prepared using the hot press method. Only the sheath region of the PLA bicomponent fiber melted, acting as an adhesive that enhanced the strength and reduced the thickness of the composite web compared with its state before hot pressing. The mechanical and physical properties of these composite webs were evaluated. Composite webs created from kapok fibers displayed a creamy yellowish-white color, while those made from cattail fibers showed a light yellowish-brown color. Additionally, the addition of natural fibers endowed the composite webs with hydrophobic properties. The maximum natural fiber content, at a ratio of 30:70 (natural fiber to PLA fiber), can be incorporated while maintaining proper water vapor permeability and mechanical properties. This nonwoven material presents an alternative with the potential to replace petroleum-based surgical gowns.

Chitosan-Coated Bacterial Cellulose (BC)/Hydrolyzed Collagen Films and Their Ascorbic Acid Loading/Releasing Performance: A Utilization of BC Waste from Kombucha Tea Fermentation.

SCOBY bacterial cellulose (BC) is a biological macromolecule (considered as a by-product) that grows at the liquid-air interface during kombucha tea fermentation. In this study, BC:HC (hydrolyzed collagen) blend films coated with 1 wt% chitosan (CS) were loaded with ascorbic acid to study loading/releasing performance. At first, the mechanical properties of the blend films were found to be dependent on HC ratio. After chitosan coating, the coated films were stronger due to intermolecular hydrogen bonding interaction and the miscibility of two matrixes at the interface. The antibacterial activity test according to the AATCC Test Method revealed that chitosan-coated BC/HC films exhibited excellent antimicrobial activity against S.aureus growth from the underneath and the above film when compared to BC and BC:HC films. Moreover, chitosan was attractive to ascorbic acid during drug loading. Consequently, its releasing performance was very poor. For BC:HC blend films, ascorbic acid loading/releasing performance was balanced by water swellability, which was controlled using blending formulation and coating. Another advantage of BC films and BC:HC blend films was that they were able to maintain active ascorbic acid for a long period of time, probably due to the presence of plenty of BC hemiacetal reducing ends (protective group).

A controlled, randomized-blinded clinical trial to assess the efficacy of a nitric oxide releasing patch in the treatment of cutaneous leishmaniasis by Leishmania (V.) panamensis.

A topical nanofiber nitric oxide (NO) releasing patch ( approximately 3.5 mumol NO/cm(2)/day for 20 days, NOP) was compared with intramuscular meglumine antimoniate (Glucantime, 20 mg/kg/day for 20 days) for the treatment of cutaneous leishmaniasis (CL) caused by Leishmania (V.) panamensis in Santander and Tolima, Colombia. A double-blind, randomized, placebo-controlled, clinical trial was conducted to determine whether the NOP is as effective as Glucantime for the treatment of CL. Patients were randomly assigned to Glucantime and placebo patches or NOP and placebo of Glucantime. The cure rates after a 3-month follow-up were 94.8% for the group that received Glucantime compared with 37.1% in the NOP group. Despite the lower efficacy of the NOP versus Glucantime, a significantly lower frequency of non-serious adverse events and a reduced variation in serum markers were observed in patients treated with NOP. Treatment of CL with NOP resulted in a lower effectiveness compared with Glucantime; however, the low frequency of adverse events and the facility of topic administration justify the development of new generations of NOP systems for the treatment of CL.

Double blind, randomized, placebo controlled clinical trial for the treatment of diabetic foot ulcers, using a nitric oxide releasing patch: PATHON.

BACKGROUND: Diabetes Mellitus constitutes one of the most important public health problems due to its high prevalence and enormous social and economic consequences. Diabetic foot ulcers are one of the chronic complications of diabetes mellitus and constitute the most important cause of non-traumatic amputation of inferior limbs. It is estimated that 15% of the diabetic population will develop an ulcer sometime in their lives. Although novel therapies have been proposed, there is no effective treatment for this pathology. Naturally produced nitric oxide participates in the wound healing process by stimulating the synthesis of collagen, triggering the release of chemotactic cytokines, increasing blood vessels permeability, promoting angiogenic activity, stimulating the release of epidermical growth factors, and by interfering with the bacterial mitochondrial respiratory chain. Topically administered nitric oxide has demonstrated to be effective and safe for the treatment of chronic ulcers secondary to cutaneous leishmaniasis. However, due to their unstable nitric oxide release, the topical donors needed to be applied frequently, diminishing the adherence to the treatment. This difficulty has led to the development of a multilayer polymeric transdermal patch produced by electrospinning technique that guarantees a constant nitric oxide release. The main objective of this study is to evaluate the effectiveness and safety of this novel nitric oxide releasing wound dressing for the treatment of diabetic foot ulcers. METHODS AND DESIGN: A double-blind, placebo-controlled clinical trial, including 100 diabetic patients was designed. At the time of enrollment, a complete medical evaluation and laboratory tests will be performed, and those patients who meet the inclusion criteria randomly assigned to one of two groups. Over the course of 90 days group 1 will receive active patches and group 2 placebo patches. The patients will be seen by the research group at least every two weeks until the healing of the ulcer or the end of the treatment. During each visit the healing process of the ulcer, the patient's health status and the presence of adverse events will be assessed. Should the effectiveness of the patches be demonstrated an alternative treatment would then be available to patients. TRIAL REGISTRATION: NCT00428727.